- Home
- MREO vs VOR Comparison
MREO vs VOR Comparison
Compare MREO & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- VOR
- Stock Information
- Founded
- MREO 2015
- VOR 2015
- Country
- MREO United Kingdom
- VOR United States
- Employees
- MREO N/A
- VOR N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- MREO Health Care
- VOR Health Care
- Exchange
- MREO Nasdaq
- VOR Nasdaq
- Market Cap
- MREO 281.6M
- VOR 261.0M
- IPO Year
- MREO N/A
- VOR 2021
- Fundamental
- Price
- MREO $1.79
- VOR $1.98
- Analyst Decision
- MREO Strong Buy
- VOR Buy
- Analyst Count
- MREO 5
- VOR 6
- Target Price
- MREO $7.40
- VOR $3.90
- AVG Volume (30 Days)
- MREO 1.2M
- VOR 5.3M
- Earning Date
- MREO 08-12-2025
- VOR 11-06-2025
- Dividend Yield
- MREO N/A
- VOR N/A
- EPS Growth
- MREO N/A
- VOR N/A
- EPS
- MREO N/A
- VOR N/A
- Revenue
- MREO $500,000.00
- VOR N/A
- Revenue This Year
- MREO N/A
- VOR N/A
- Revenue Next Year
- MREO $55.50
- VOR N/A
- P/E Ratio
- MREO N/A
- VOR N/A
- Revenue Growth
- MREO N/A
- VOR N/A
- 52 Week Low
- MREO $1.47
- VOR $0.13
- 52 Week High
- MREO $4.72
- VOR $3.29
- Technical
- Relative Strength Index (RSI)
- MREO 52.86
- VOR 48.82
- Support Level
- MREO $1.68
- VOR $2.05
- Resistance Level
- MREO $1.83
- VOR $2.02
- Average True Range (ATR)
- MREO 0.08
- VOR 0.16
- MACD
- MREO 0.03
- VOR -0.03
- Stochastic Oscillator
- MREO 82.61
- VOR 13.11
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.